ClinicalTrials.Veeva

Menu

Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC

S

Shandong Branden Med.Device

Status

Not yet enrolling

Conditions

the Incidence of PICC-related Complications

Treatments

Device: PICC

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05621473
brandentech-001

Details and patient eligibility

About

This study was designed as a prospective, multicenter, randomized controlled study, with the incidence of postoperative complications as the main observation end point. It was a superiority design.The purpose of this study was to compare the incidence of complications associated with EDUG-guided subcutaneous tunneling and conventional puncture after peripheral vein placement of PICCs

Enrollment

420 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years old;

  • Immunocompromised patients, including:

    ① Patients with congenital T cell/B cell deficiency or macrophage disorder;

    ② Patients with solid malignant tumors or hematological malignancies;

    ③ Patients with AIDS;

    ④ Patients undergoing splenectomy or solid organ transplantation;

    ⑤ Patients with rheumatic diseases and treated with immunomodulatory drugs;

  • Follow the doctor's advice to perform PICC catheterization for the first time;

  • No serious cardiovascular disease, such as atrial fibrillation, pulmonary heart disease, severe conduction block, etc., before catheter placement;

  • Patients who have not participated in other clinical studies;

  • Patients who voluntarily participate in the clinical study and can cooperate with the clinical follow-up.

Exclusion criteria

  • Known allergy to catheter material;
  • History of infection, injury or radiation therapy at the puncture site;
  • There is a history of venous thrombosis or surgical operation at the puncture site;
  • Severe abnormal coagulation function;
  • Superior vena cava compression syndrome;
  • Radical mastectomy for breast cancer or axillary lymph node dissection on the operative side of the limb;
  • Pacemaker and arteriovenous fistula ipsilateral limb.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

420 participants in 2 patient groups

trial group
Experimental group
Description:
This arm of patients received tunnel PICC interventions
Treatment:
Device: PICC
control group
Experimental group
Description:
This arm of patients received normal PICC interventions
Treatment:
Device: PICC

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems